Prostate MR Imaging for Posttreatment Evaluation and Recurrence

Sonia Gaur; Baris Turkbey

doi:10.1016/j.rcl.2017.10.008

Prostate MR Imaging for Posttreatment Evaluation and Recurrence

Radiol Clin North Am. 2018 Mar;56(2):263-275. doi: 10.1016/j.rcl.2017.10.008. Epub 2017 Nov 27.

Authors

Sonia Gaur¹, Baris Turkbey²

Affiliations

¹ Molecular Imaging Program, National Cancer Institute, National Institutes of Health, 10 Center Drive, Building 10, Room B3B85, Bethesda, MD 20814, USA.
² Molecular Imaging Program, National Cancer Institute, National Institutes of Health, 10 Center Drive, Building 10, Room B3B85, Bethesda, MD 20814, USA. Electronic address: turkbeyi@mail.nih.gov.

Abstract

Prostate multiparametric MR imaging (mpMRI) plays an important role in local evaluation after treatment of prostate cancer. After radical prostatectomy, radiation therapy, and focal therapy, mpMRI can be used to visualize normal post-treatment changes and to diagnose locally recurrent disease. An understanding of the various treatments and expected changes is essential for complete and accurate post-treatment mpMRI interpretation.

Keywords: Focal therapy; Prostate cancer; Radiation therapy; Radical prostatectomy; Recurrence; mpMRI.

Published by Elsevier Inc.

Publication types

Review

MeSH terms

Humans
Magnetic Resonance Imaging / methods*
Male
Neoplasm Recurrence, Local / diagnostic imaging*
Neoplasm Recurrence, Local / pathology
Postoperative Complications / diagnostic imaging*
Prostate / diagnostic imaging*
Prostate / pathology
Prostatic Neoplasms / diagnostic imaging*
Prostatic Neoplasms / pathology
Prostatic Neoplasms / surgery*

Grants and funding

Z99 CA999999/ImNIH/Intramural NIH HHS/United States